Located in Doha, Sidra Medicine is a private, not-for-profit academic healthcare and research institution dedicated to women, children, and young people. Established by Qatar Foundation for Education, Science, and Community Development, Sidra Medicine integrates exceptional patient- and family-centered care with innovative biomedical and clinical research. The organization advances precision medicine, particularly in rare and genetic diseases.
At the center of its personalized medicine mission is the Advanced Cell Therapy Core (ACTC), a GMP-compliant facility embedded within Sidra Medicine’s hospital and research environment. The ACTC supports advanced therapy development across hematopoietic stem cell transplantation, regenerative medicine, gene therapy, and CAR-T technologies. As Qatar’s only GMP-compliant cell processing facility of its kind, the Core plays a critical role in translating research into safe and clinically applicable therapies for patients locally and globally.
A Strong and Constructive Accreditation Experience
Sidra Medicine describes its partnership with Perry Johnson Laboratory Accreditation (PJLA) as professional, rigorous, and highly constructive. The accreditation process was viewed as an opportunity to further strengthen internal systems and elevate operational excellence. Through collaboration with PJLA, ACTC enhanced its quality management systems and reinforced internationally recognized best practices. The accreditation is another milestone in the organization’s commitment to continuous improvement.
The accreditation experience provided meaningful external validation of the team’s technical expertise and quality-focused culture. It strengthened operational consistency and ensured alignment with global standards that support safe and reliable therapy development.
The Value of ISO/IEC 17025 Accreditation
Achieving ISO/IEC 17025 accreditation provides independent confirmation of laboratory technical competence. It also validates the reliability and reproducibility of testing processes. For an advanced therapy facility like ACTC, this level of validation is essential.
Accreditation strengthens confidence among clinical, pharmaceutical, and industry partners. It demonstrates compliance with globally recognized standards, including alignment with GMP requirements. In advanced therapy development, patient safety and regulatory confidence are critical. International collaboration depends on trust in laboratory quality systems. ISO 17025 accreditation supports all these priorities.
Sidra Medicine views accreditation as more than a credential. It is a foundation for trust and accountability. It supports regulatory engagement, enhances international partnerships, and reinforces the organization’s responsibility to ensure emerging therapies are developed and delivered with the highest levels of quality and safety.
Advancing the Future of Precision Medicine
Sidra Medicine is distinguished by its integrated environment where clinical care, research, and advanced therapy production coexist within a leading academic medical center. The Advanced Cell Therapy Core is defined by:
- GMP-compliant product quality control and therapeutic production infrastructure embedded within a specialized hospital setting
- Integration of precision medicine into translational research programs
- Commitment to internationally recognized quality and regulatory standards
- Strategic location supporting regional and global collaboration
- A focused dedication to innovation in women’s and children’s health
Looking ahead, ACTC aims to further strengthen its GMP-enabled capabilities. The team continues to expand its scope across hematopoietic stem cell processing, MSC-based therapies, regenerative medicine products, gene therapy approaches, and CAR-T production. These efforts support the responsible translation of advanced therapies from concept to patient application.
Guided by innovation and compassion, Sidra Medicine strives to transform lives through exceptional care, groundbreaking research, and education. Through its accreditation journey and ongoing commitment to quality, Sidra Medicine continues to reinforce its vision of being a beacon of learning, discovery, and exceptional care, ranked among the top academic medical centers in the world.
Contact Sidra Medicine
Address: Al Gharrafa Street, Ar-Rayyan, Doha, Qatar
Telephone: +974 4003 3333
CE Marking is one of the most recognized symbols in global trade. Yet few manufacturers and conformity assessment bodies understand the legal framework behind it. Based on insights from a recent webinar by Perry Johnson Laboratory Accreditation (PJLA), this article breaks down the EU notification process, explains why accreditation alone is not enough, and outlines how products legally gain access to the European market.
ISO/IEC 17025 applies to laboratories performing testing and calibration activities. Clauses 7.6 and 7.7 work together to ensure that laboratory results are both technically valid and consistently reliable.
At PJLA (PJLA), we specialize in accreditation of labs and testing services, ensuring food, beverage, and consumer product safety and compliance. This Halloween, our focus turns to the treat bowl: how testing, allergen verification, and robust control help manufacturers, retailers and families enjoy the fun with confidence.
In the world of accreditation, impartiality is everything. Without it, the credibility of any conformity assessment body (CAB), whether a testing or calibration laboratory, inspection agency, or certification body, quickly unravels. Yet, as PJLA’s Technical & International Business Development Manager Dr. George Anastasopoulos has observed through years of accreditation assessments, many CABs still treat impartiality as a simple compliance box to check rather than a living, breathing part of their management system.
In his recent LinkedIn article, PJLA’s Technical & International Business Development Manager, Dr. George Anastasopoulos, reflects on why process-based auditing, though introduced with ISO 9001:2000, continues to challenge auditors/assessors more than two decades later.
Article from Dr. George Anastasopoulos
By Dr. George Anastasopoulos
